Ifetroban
CPI-IFE-007
Phase 2 small_molecule completed
Quick answer
Ifetroban for Duchenne Muscular Dystrophy Cardiomyopathy is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Duchenne Muscular Dystrophy Cardiomyopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed